Idelalisib

ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
Flag link:
6 Drugs That Could Move the Pharma Market
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Flag link:
Standard Review for Gilead's Oncology Candidate
Standard Review for Gilead's Oncology Candidate
Yahoo/Zacks.com
Gilead Sciences
Idelalisib
refractory indolent non-Hodgkins lymphoma
Flag link:
FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
Yahoo
FDA
Gilead Sciences
Idelalisib
refractory indolent non-Hodgkins lymphoma
Flag link:
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Gilead
Idelalisib
CLL
chronic lymphocytic leukemia
Flag link:
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Gilead Sciences
Idelalisib
Rituxan
chronic lymphocytic leukemia
Flag link:
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
Flag link:
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
Flag link: